UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 66

Sortiert nach

High Fructose Drives the Serine Synthesis Pathway in Acute Myeloid Leukemic Cells

Cell metabolism, 2021-01, Vol.33 (1), p.145-159.e6

2021

Volltextzugriff (PDF)

On mice and humans: the role of thymic stromal lymphopoietin in human B-cell development and leukemia

Haematologica (Roma), 2016-04, Vol.101 (4), p.391

2016

Volltextzugriff (PDF)

Suppressors and activators of JAK-STAT signaling at diagnosis and relapse of acute lymphoblastic leukemia in Down syndrome

Proceedings of the National Academy of Sciences - PNAS, 2017-05, Vol.114 (20), p.E4030-E4039

2017

Volltextzugriff (PDF)

An instructive role for Interleukin-7 receptor α in the development of human B-cell precursor leukemia

Nature communications, 2022-02, Vol.13 (1), p.659-659, Article 659

2022

Volltextzugriff (PDF)

Synergistic drug interactions of the histone deacetylase inhibitor givinostat (ITF2357) in CRLF2-rearranged pediatric B-cell precursor acute lymphoblastic leukemia identified by high-throughput drug screening

Heliyon, 2024-07, Vol.10 (13), p.e34033, Article e34033

2024

Volltextzugriff (PDF)

Fine tuning of surface CRLF2 expression and its associated signaling profile in childhood B-cell precursor acute lymphoblastic leukemia

Haematologica (Roma), 2015-06, Vol.100 (6), p.e229

2015

Volltextzugriff (PDF)

PAX5 fusion genes are frequent in poor risk childhood acute lymphoblastic leukaemia and can be targeted with BIBF1120

EBioMedicine, 2022-09, Vol.83, p.104224-104224, Article 104224

2022

Volltextzugriff (PDF)

Interleukin-7 signaling as a therapeutic target in acute lymphoblastic leukemia

Expert review of hematology, 2017-03, Vol.10 (3), p.183-185

2017

Volltextzugriff (PDF)

High-throughput screening as a drug repurposing strategy for poor outcome subgroups of pediatric B-cell precursor Acute Lymphoblastic Leukemia

Biochemical pharmacology, 2023-11, Vol.217, p.115809-115809, Article 115809

2023

Volltextzugriff (PDF)

Fructose Treatment Targets Myeloid Leukemogenesis in IDH2 Mutants By Exhausting Alpha-Ketoglutarate Pools

Blood, 2022-11, Vol.140 (Supplement 1), p.2966-2967

2022

Volltextzugriff (PDF)

Pre-Clinical Efficacy of the Novel Kinase Inhibitor Nintedanib on PAX5 Fusion Genes in Pediatric Ph-like B-Cell Precursor Acute Lymphoblastic Leukemia

Blood, 2019-11, Vol.134 (Supplement_1), p.745-745

2019

Volltextzugriff (PDF)

Stearoyl-CoA Desaturase (SCD) Enhances Central Nervous System Leukemia

Blood, 2018-11, Vol.132 (Supplement 1), p.389-389

2018

Volltextzugriff (PDF)

Activation of CRLF2/IL7RA Signaling in Normal Human Cord Blood Hematopoietic Progenitors Induces Philadelphia-like B-Cell Precursor Pre-Leukemia and Leukemia In Vivo

Blood, 2018-11, Vol.132 (Supplement 1), p.566-566

2018

Volltextzugriff (PDF)

Mass Cytometry Analysis Dissects CRLF2-Driven Signaling Pathways in Childhood B-Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL)

Blood, 2015-12, Vol.126 (23), p.906-906

2015

Volltextzugriff (PDF)

Role of the Histone Deacetylase Inhibitor Givinostat (ITF2357) in Treatment of CRLF2 Rearranged Acute Lymphoblastic Leukemia

Blood, 2015-12, Vol.126 (23), p.2534-2534

2015

Volltextzugriff (PDF)

14th International Congress on Antiphospholipid Antibodies Task Force. Report on antiphospholipid syndrome laboratory diagnostics and trends

Autoimmunity reviews, 2014-09, Vol.13 (9), p.917-930

2014

Volltextzugriff (PDF)

Immune response to one dose of BNT162b2 mRNA Covid-19 vaccine followed by SARS-CoV-2 infection: An Italian prospective observational study

Vaccine, 2022-03, Vol.40 (12), p.1805-1809

2022

Volltextzugriff (PDF)

2023 ACR/EULAR antiphospholipid syndrome classification criteria

Annals of the rheumatic diseases, 2023-10, Vol.82 (10), p.1258

2023

Volltextzugriff (PDF)

Identification of protective and broadly conserved vaccine antigens from the genome of extraintestinal pathogenic Escherichia coli

Proceedings of the National Academy of Sciences - PNAS, 2010-05, Vol.107 (20), p.9072-9077

2010

Volltextzugriff (PDF)

The 2023 ACR / EULAR Antiphospholipid Syndrome Classification Criteria

Arthritis & rheumatology (Hoboken, N.J.), 2023-10, Vol.75 (10), p.1687-1702

2023

Volltextzugriff (PDF)

Development of a New International Antiphospholipid Syndrome Classification Criteria Phase I/II Report: Generation and Reduction of Candidate Criteria

Arthritis care & research (2010), 2021-10, Vol.73 (10), p.1490-1501

2021

Volltextzugriff (PDF)

1 – 25 von 66

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(62)
Mit Volltextzugriff
(54)

Publikationsform

Artikel
(65)
Berichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(46)
Life Sciences & Biomedicine
(42)
Humans
(39)
Female
(15)
Antiphospholipid Syndrome
(14)
Male
(14)
Rheumatology
(12)
Antiphospholipid Antibodies
(10)
Child
(9)
Risk Factors
(9)
Antibodies, Antiphospholipid
(8)
Thrombosis
(8)
Covid-19
(7)
Animals
(6)
Antiphospholipid Syndrome - Complications
(6)
Autoimmune Diseases
(6)
Antibodies
(5)
Antiphospholipid Syndrome - Diagnosis
(5)
Clinical Trials
(5)
General & Internal Medicine
(5)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

High Fructose Drives the Serine Synthesis Pathway in Acute Myeloid Leukemic Cells

On mice and humans: the role of thymic stromal lymphopoietin in human B-cell development and leukemia

Suppressors and activators of JAK-STAT signaling at diagnosis and relapse of acute lymphoblastic leukemia in Down syndrome

An instructive role for Interleukin-7 receptor α in the development of human B-cell precursor leukemia

Synergistic drug interactions of the histone deacetylase inhibitor givinostat (ITF2357) in CRLF2-rearranged pediatric B-cell precursor acute lymphoblastic leukemia identified by high-throughput drug screening

Fine tuning of surface CRLF2 expression and its associated signaling profile in childhood B-cell precursor acute lymphoblastic leukemia

PAX5 fusion genes are frequent in poor risk childhood acute lymphoblastic leukaemia and can be targeted with BIBF1120

Interleukin-7 signaling as a therapeutic target in acute lymphoblastic leukemia

High-throughput screening as a drug repurposing strategy for poor outcome subgroups of pediatric B-cell precursor Acute Lymphoblastic Leukemia

Fructose Treatment Targets Myeloid Leukemogenesis in IDH2 Mutants By Exhausting Alpha-Ketoglutarate Pools

Pre-Clinical Efficacy of the Novel Kinase Inhibitor Nintedanib on PAX5 Fusion Genes in Pediatric Ph-like B-Cell Precursor Acute Lymphoblastic Leukemia

Stearoyl-CoA Desaturase (SCD) Enhances Central Nervous System Leukemia

Activation of CRLF2/IL7RA Signaling in Normal Human Cord Blood Hematopoietic Progenitors Induces Philadelphia-like B-Cell Precursor Pre-Leukemia and Leukemia In Vivo

Mass Cytometry Analysis Dissects CRLF2-Driven Signaling Pathways in Childhood B-Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL)

Role of the Histone Deacetylase Inhibitor Givinostat (ITF2357) in Treatment of CRLF2 Rearranged Acute Lymphoblastic Leukemia

Metabolic adaptation of acute lymphoblastic leukemia to the central nervous system microenvironment is dependent on Stearoyl CoA desaturase

14th International Congress on Antiphospholipid Antibodies Task Force. Report on antiphospholipid syndrome laboratory diagnostics and trends

Immune response to one dose of BNT162b2 mRNA Covid-19 vaccine followed by SARS-CoV-2 infection: An Italian prospective observational study

2023 ACR/EULAR antiphospholipid syndrome classification criteria

Identification of protective and broadly conserved vaccine antigens from the genome of extraintestinal pathogenic Escherichia coli

The 2023 ACR / EULAR Antiphospholipid Syndrome Classification Criteria

Cluster analysis for the identification of clinical phenotypes among antiphospholipid antibody-positive patients from the APS ACTION Registry

Circulating immune-complexes of IgG/IgM bound to B2-glycoprotein-I associated with complement consumption and thrombocytopenia in antiphospholipid syndrome

Development of a New International Antiphospholipid Syndrome Classification Criteria Phase I/II Report: Generation and Reduction of Candidate Criteria

The adjusted global antiphospholipid syndrome score (aGAPSS) and the risk of recurrent thrombosis: Results from the APS ACTION cohort

Suchergebnisse filtern